ArticleFrontiers in aging neuroscience2025
Handgrip strength and risk of cognitive impairment across different glucose metabolism statuses: insights from the CHARLS study.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The association between handgrip strength, physical, and cognitive function among hospitalized older adults in Tanzania.BMC geriatrics · 2026Article
- Joint associations of handgrip strength and functional disability with cognitive impairment in older adults.European journal of medical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Both low handgrip strength (HGS) and abnormal glucose metabolism have been implicated in an increased risk of cognitive impairment. However, whether HGS interacts with glucose metabolism status to influence cognitive function remains unclear. This study explores the relationship between HGS and cognitive impairment risk among middle-aged and older Chinese adults and examines the potential modulation of this association by glucose metabolism status. Methods: Data from the China Health and Retirement Longitudinal Study (CHARLS) collected in 2011 and 2018 were analyzed, including 7,301 participants aged ≥ 45 years. Cognitive impairment was the primary outcome. Logistic regression and restricted cubic spline (RCS) analyses were applied to evaluate the association between HGS and cognitive impairment risk across different glucose metabolism statuses. Results: The study included 7,301 participants (mean age: 58.8 ± 8.9 years; 49.3% female). Over a 7-year follow-up, the mean cognitive function score declined from 12.05 ± 3.30 to 7.75 ± 5.70. After adjusting for confounders, logistic regression analyses indicated that higher HGS was significantly associated with a lower risk of cognitive impairment. Participants in the highest HGS quartile (Q4) had a significantly reduced odds of cognitive impairment compared to those in the lowest quartile (Q1) (odds ratio [OR]: 0.59, 95% confidence interval [CI]: 0.49-0.71; Conclusion: Higher HGS is significantly associated with a reduced risk of cognitive impairment among middle-aged and older individuals, irrespective of glucose metabolism status. These findings suggest that HGS assessment could be a valuable universal tool for evaluating cognitive impairment risk, regardless of metabolic conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.